| TECHNOLOGY TRANSFER Active members of the biotechnology/biomedical research community may have developed a new technology, a potential pharmaceutical, or a new diagnostic procedure that would be of interest to other researchers or to commercial pharmaceutical, healthcare or reagent manufacturers. The transfer or licensing of these technologies can provide additional substantial funds for their own research as well as help expedite their use in research and healthcare worldwide. REAGENT MARKETING Additionally, they may have developed biological reagents, including monoclonal or polyclonal antibodies, purified antigens, proteins or other specialized reagents that would be of interest to other researchers in universities or commercial laboratories. These reagents represent an asset that can improve the level of funding for their research activities. They can be commercialized quickly with only a minor amount of time on the researcher's part. THE EVEREST PARTNERSHIP EVEREST's principal, Dr. Elliott Block, has over thirty years experience in the worldwide commercialization of diagnostics, research reagents and pharmaceutical technologies with large, multinational and small, entrepreneurial firms. He has negotiated multimillion-dollar in-licensing and out-licensing technology transfers and international distribution agreements. EVEREST offers a unique opportunity to become a partner in the commercialization of these biotechnology/biomedical reagents. EVEREST can successfully assist in bringing new technologies and/or reagents from the research laboratory to the market place. These technologies and/or reagents will be commercialized quickly, effectively and with minimal effect on the researcher's ongoing activities . HOW THE PARTNERSHIP WORKS The technology or reagents are submitted to EVEREST to evaluate their commercial potential. A royalty agreement is formulated that provides for financial compensation based on a percentage of worldwide sales. A well-established sales operation and worldwide distribution network will give the reagents the opportunity to achieve market penetration quickly. The technology or reagents will become available to the worldwide research community, facilitating further investigations in the field. The royalty stream generated through the partnership will assist the laboratory in continuing and increasing the researcher's efforts. [Some facilities allow their researchers to personally receive a portion of the income; please check with your institution.] ************** CALL DR. ELLIOTT BLOCK NOW: 1-561-487-7747 [email protected] |
 |
| EVEREST ASSOCIATES |
 |